Memantine and Naltrexone Treatment for Opioid Dependence
Completed · Phase 2 · Has a placebo group
Conditions studied: Opioid Dependence
In brief
The goal of this study is to test the efficacy of memantine (a noncompetitive NMDA receptor antagonist) as an adjunct to the maintenance treatment with naltrexone in detoxified heroin-dependent individuals.
Key facts
- Study ID
- NCT00125515
- Run by
- New York State Psychiatric Institute
- People needed
- 81
- Starts
- 2005-06-01
- Expected to finish
- 2008-08-01
- Last updated by the study team
- 2018-06-18
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- New York State Psychiatric Institute — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.